Original Publication Date: 1 October, 2014
Publication / Source: Future Oncology
Authors: Manish K Pant, Ahmed Abughaban, Jeanny B Aragon-Ching
The landscape of treatment for metastatic castration-resistant prostate cancer has rapidly evolved during the last 5 years alone. In this review, standard therapies as well as recent advances in the systemic treatment for prostate cancer are explored. Pivotal trial data are summarized with emphasis on indications for various anti-androgen drugs, androgen-biosynthesis inhibitors, chemotherapy, immunotherapy and bone-targeted agents.